Legal News

Life Sciences weekly highlights—12 May 2022

Published on: 12 May 2022
Published by: LexisPSL
  • Life Sciences weekly highlights—12 May 2022
  • In this issue:
  • Manufacture, marketing and sale
  • FDA’s use of advisory committees prior to drug approval decreased over the last decade
  • EMA publishes new ICH guideline on elemental impurities
  • Intellectual property
  • Pregabalin litigation—damages inquiries arising from cross-undertakings in damages
  • Medical devices
  • Ukraine conflict—Commission publishes recommendation to Notified Bodies in EU
  • Coronavirus (COVID-19)
  • More...

Article summary

This week's edition of Life Sciences weekly highlights includes analysis of the US FDA’s use of advisory committees prior to approving drugs, analysis of inquiry as to damages in pharmaceutical patent disputes, news on the EMA’s new ICH guideline on elemental impurities, the European Commission’s recommendation to Notified Bodies in relation to the Ukraine conflict and complying with sanctions, and a preliminary agreement on a vaccine IP waiver between the EU, India, South Africa and the US. or take a trial to read the full analysis.

Popular documents